Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00334919 · ClinicalTrials.gov registry record · Phase 2
RCT of the Naturopathic Anti-Inflammatory Diet
A Phase 2 study, sponsored by National University of Natural Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT00334919: Completed Phase 2 study, sponsored by National University of Natural Medicine.
NCT00334919 is a Phase 2 study that has completed, run by National University of Natural Medicine. The registered enrollment target is 30 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (77% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00334919, a Phase 2 study, has completed, sponsored by National University of Natural Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if the naturopathic Anti-Inflammatory Diet results in reduced inflammation and a better response by the immune system when compared to a standard diabetic diet based on the current American Diabetes Association guidelines.
Interventions
- BEHAVIORAL Diet (Anti-Inflammatory or standard diabetic diet)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2006-05 |
| Est. Completion | 2007-12 |
| Phase | Phase 2 |
What the finished NCT00334919 record still lists
NCT00334919 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (77% lower).
The record links to 0 conditions, and to 1 intervention - of which Diet (Anti-Inflammatory or standard diabetic diet) is the first listed.
NCT00334919 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00334919 about?
NCT00334919 is a clinical study titled "RCT of the Naturopathic Anti-Inflammatory Diet". The purpose of this study is to determine if the naturopathic Anti-Inflammatory Diet results in reduced inflammation and a better response by the immune system when compared to a standard diabetic diet based on the current American Diabetes Association guidelines.
What is the current status of trial NCT00334919?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2006-05. Estimated completion is 2007-12.
What interventions are being tested in trial NCT00334919?
The interventions under investigation include: Diet (Anti-Inflammatory or standard diabetic diet) (BEHAVIORAL).
Who is sponsoring clinical trial NCT00334919?
This trial is sponsored by National University of Natural Medicine, which has 30 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00334919's enrollment target sits among peer trials
30 1582nd of 2000 higher than 332 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00977977 · 30 participants · Phase 2
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
- NCT01459107 · 30 participants · Phase 2
Human Upper Extremity Allotransplantation
- NCT01666080 · 30 participants · NA
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
- NCT01720836 · 30 participants · Phase 1
Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia